Correlation Between Veracyte and Iovance Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both Veracyte and Iovance Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Veracyte and Iovance Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Veracyte and Iovance Biotherapeutics, you can compare the effects of market volatilities on Veracyte and Iovance Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Veracyte with a short position of Iovance Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Veracyte and Iovance Biotherapeutics.
Diversification Opportunities for Veracyte and Iovance Biotherapeutics
-0.66 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Veracyte and Iovance is -0.66. Overlapping area represents the amount of risk that can be diversified away by holding Veracyte and Iovance Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Iovance Biotherapeutics and Veracyte is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Veracyte are associated (or correlated) with Iovance Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Iovance Biotherapeutics has no effect on the direction of Veracyte i.e., Veracyte and Iovance Biotherapeutics go up and down completely randomly.
Pair Corralation between Veracyte and Iovance Biotherapeutics
Given the investment horizon of 90 days Veracyte is expected to generate 0.86 times more return on investment than Iovance Biotherapeutics. However, Veracyte is 1.16 times less risky than Iovance Biotherapeutics. It trades about 0.24 of its potential returns per unit of risk. Iovance Biotherapeutics is currently generating about -0.34 per unit of risk. If you would invest 4,044 in Veracyte on November 2, 2024 and sell it today you would earn a total of 570.00 from holding Veracyte or generate 14.09% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Veracyte vs. Iovance Biotherapeutics
Performance |
| Timeline |
| Veracyte |
| Iovance Biotherapeutics |
Veracyte and Iovance Biotherapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Veracyte and Iovance Biotherapeutics
The main advantage of trading using opposite Veracyte and Iovance Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Veracyte position performs unexpectedly, Iovance Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Iovance Biotherapeutics will offset losses from the drop in Iovance Biotherapeutics' long position.| Veracyte vs. Crinetics Pharmaceuticals | Veracyte vs. Viridian Therapeutics | Veracyte vs. Cytokinetics | Veracyte vs. Structure Therapeutics American |
| Iovance Biotherapeutics vs. PTC Therapeutics | Iovance Biotherapeutics vs. Krystal Biotech | Iovance Biotherapeutics vs. Sarepta Therapeutics | Iovance Biotherapeutics vs. Madrigal Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |